Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucocerebrosidase: Functions in and Beyond the Lysosome
Daphne E.C. Boer, Jeroen van Smeden, Joke A. Bouwstra, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 3, pp. 736-736
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Mylene Huebecker, Elizabeth B. Moloney, Aarnoud C. van der Spoel, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 134
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
Patricia García‐Sanz, Johannes M. F. G. Aerts, Rosario Moratalla
Movement Disorders (2020) Vol. 36, Iss. 5, pp. 1070-1085
Open Access | Times Cited: 89
Novel targeted therapies for Parkinson’s disease
Theodora Ntetsika, Paraskevi-Evita Papathoma, Ioanna Markaki
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 78
Sphingolipid metabolism during Toll‐like receptor 4 (TLR4)‐mediated macrophage activation
Antoni Olona, Charlotte Hateley, Sneha Muralidharan, et al.
British Journal of Pharmacology (2021) Vol. 178, Iss. 23, pp. 4575-4587
Open Access | Times Cited: 67
DAXX adds a de novo H3.3K9me3 deposition pathway to the histone chaperone network
Massimo Carraro, Ivo A. Hendriks, Colin M. Hammond, et al.
Molecular Cell (2023) Vol. 83, Iss. 7, pp. 1075-1092.e9
Open Access | Times Cited: 41
Endolysosomal trapping of therapeutics and endosomal escape strategies
Aqeel Ahmad, Javed Masood Khan, Bilal Ahamad Paray, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104070-104070
Closed Access | Times Cited: 11
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct
Alexandra Gehrlein, Vinod Udayar, Nadia Anastasi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
A Phase 1B Trial in GBA1‐Associated Parkinson's Disease of BIA‐28‐6156, a Glucocerebrosidase Activator
Jonas M. den Heijer, Annelieke C. Kruithof, Matthijs Moerland, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1197-1208
Open Access | Times Cited: 21
Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson’s iPSC-dopamine neurons
Dayne Beccano-Kelly, Marta Cherubini, Yassine Mousba, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107044-107044
Open Access | Times Cited: 21
Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models
Alice Drobny, Fanni Annamária Boros, Denise Balta, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Gaucher disease: Basic and translational science needs for more complete therapy and management
Gregory A. Grabowski, Armand H. Matheny Antommaria, Edwin H. Kolodny, et al.
Molecular Genetics and Metabolism (2020) Vol. 132, Iss. 2, pp. 59-75
Open Access | Times Cited: 45
The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson’s disease
Sonia Sanz Muñoz, Daniel Petersen, Frederik Ravnkilde Marlet, et al.
Biophysical Chemistry (2020) Vol. 273, pp. 106534-106534
Open Access | Times Cited: 41
Impaired neuron differentiation in GBA-associated Parkinson’s disease is linked to cell cycle defects in organoids
Isabel Rosety, Alise Žagare, Cláudia Saraiva, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Lysosome function in glomerular health and disease
Catherine Meyer-Schwesinger
Cell and Tissue Research (2021) Vol. 385, Iss. 2, pp. 371-392
Open Access | Times Cited: 28
Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions
Casey L. Mahoney-Crane, Megha Viswanathan, Drèson L. Russell, et al.
Journal of Neuroscience (2022) Vol. 43, Iss. 3, pp. 501-521
Open Access | Times Cited: 21
Deregulation of mTORC1-TFEB axis in human iPSC model of GBA1-associated Parkinson’s disease
Fahad Mubariz, Afsoon Saadin, Nicholas Lingenfelter, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy
Ryan Conesa-Bakkali, Macarena Morillo‐Huesca, Jonathan Martínez‐Fábregas
Cells (2025) Vol. 14, Iss. 2, pp. 68-68
Open Access
Impact of LRRK2 and GBA variants on orthostatic hypotension in patients with Parkinson’s disease
Wen Liu, Yinlian Han, Yuqian Liu, et al.
Journal of Neurology (2025) Vol. 272, Iss. 5
Closed Access
Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson’s disease
Manoj Kumar, Manasa P. Srikanth, Michela Deleidi, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 11, pp. 1888-1900
Open Access | Times Cited: 10
Ligand Activation of the Aryl Hydrocarbon Receptor Upregulates Epidermal Uridine Diphosphate Glucose Ceramide Glucosyltransferase and Glucosylceramides
Thomas R. Sutter, Shafquat Azim, Anyou Wang, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 10, pp. 1964-1972.e4
Open Access | Times Cited: 10
The role of exosomes in the diagnosis of Parkinson's disease
Qingqing Shi, Wei Kang, Zhijun Liu, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20595-e20595
Open Access | Times Cited: 9
Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications
Wei Zheng, Dongsheng Fan
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 14
Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy
Fatemeh Moradbeygi, Younes Ghasemi, Ahmad Reza Farmani, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115292-115292
Open Access | Times Cited: 7
The autophagy–lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson’s disease
Fengjuan Jiao, Lingyan Meng, Kang Du, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 139-158
Open Access | Times Cited: 2
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?
Daniel Foran, Charalambos Antoniades, Ioannis Akoumianakis
(2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top